EU GMP

EU GMP readiness, without the guesswork.

EU GMP — the European Union’s manufacturing standard, published as EudraLex Volume 4 — is where cannabis, pharmaceutical, and equipment manufacturers have to arrive to sell into Europe. We help you get there: gap assessment, remediation, integrated quality systems, and the export-readiness work that closes the gap between where you are and what a European inspector expects.

Who we get EU-GMP-ready

Cannabis exporters

State-licensed cultivators and manufacturers building to EU GACP + GMP for export — the gap assessment, the Qualified Person path, and the remediation roadmap.

Pharma & CMOs

Finished-product and active-substance manufacturers building one quality system to the highest common bar across EU GMP, FDA, and ICH.

Equipment makers (OEM)

Turning an operations manual into a GMP-aligned equipment documentation package customers can use for IQ/OQ qualification.

Start here — the EU GMP cluster

Long-form, practitioner-written pieces that map the whole terrain — from the standard itself to qualifying a single machine.

EU GMP vs. FDA GMP

The two frameworks overlap 70–80%. Export programs fail in the 20% that diverges: the Qualified Person, the annex system, contamination control, and the distinct EU GDP regime. A clause-level comparison.

Read the piece

EU GMP — frequently asked

What is EU GMP?

EU GMP (Good Manufacturing Practice) is the European Union's framework for manufacturing medicinal products and active substances, published as EudraLex Volume 4. It is principle-based and elaborated through a system of annexes, and it requires a Pharmaceutical Quality System (ICH Q10), risk management (ICH Q9), and certification of every batch by a Qualified Person before release.

What is the difference between EU GMP and FDA GMP?

EU GMP (EudraLex Volume 4) and FDA GMP (21 CFR Parts 210 and 211) agree on roughly 70–80% of substance. The expensive differences are structural: the EU requires a named Qualified Person to certify every batch, an explicit ICH Q10 quality system, a numbered annex system, a Site Master File, and a distinct Good Distribution Practice regime. Export programs fail in that diverging 20%, not the overlap.

How does ICH relate to EU GMP?

The EU is a founding regulatory member of ICH, and EudraLex Volume 4 adopts ICH guidelines at its load-bearing points — Part II is ICH Q7, the required quality system is ICH Q10, and risk management is ICH Q9. Building a quality system, stability program, and analytical methods to ICH therefore builds to the structural core of EU GMP, once, for every European market.

Do I need EU GMP certification to export to Europe?

Manufacturing for the EU medicinal market requires compliance with EU GMP and, for finished products, certification of each batch by a Qualified Person. Intrepid gets an operation ready to meet that bar — gap assessment, remediation, and quality-system build — but readiness is not the grant: national competent authorities and the Qualified Person make the compliance and release decisions.

What is an EU GMP gap assessment?

An EU GMP gap assessment maps a cultivation and manufacturing operation against EudraLex Volume 4 (Parts I and II) and the relevant annexes, identifies the deltas that gate export — the Qualified Person, Annex 1 contamination control, the Site Master File, Annex 15 validation, EU GDP — and delivers a prioritized, sequenced remediation roadmap. It is the scoped Stage 1 that defines the rest of the work.

Is my equipment EU GMP compliant?

Equipment is never 'GMP compliant' on its own — GMP is a property of an operation, not a machine. Equipment can be made qualifiable: designed to GMP engineering principles and shipped with the controlled documentation a regulated buyer needs to qualify it (DQ, IQ, OQ, PQ) under Annex 15. CE/PED/ATEX conformity marking is a separate question from GMP qualification.

How long does EU GMP readiness take?

It depends on the starting state and scope, which is exactly what a Stage 1 gap assessment determines. Realistic programs are phased and decision-gated: a scoping and gap assessment first, then remediation and quality-system build, with the Qualified Person timeline typically on the critical path for export.

Building toward Europe?

Tell us where you are. The most useful first move is usually a short note describing the operation — we’ll tell you honestly what EU GMP readiness takes from here.